A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19
NCT05035576
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor Decision
Conditions
Covid19
Interventions
DRUG:
OPN-019
Sponsor
Optinose US Inc.